Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


News SummaryMost relevantAll newsSector news 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
React to this article
Latest news on BAYER AG
09:29aDJBayer's EYLEA Gets EU Approval for Retinal Vein Occlusion Treatment
08:41a BAYER : Dr. Richard Pott to be Chairman of the Supervisory Board of Bayer Materi..
06:08aDJBayer Reiterates Plans to Divest Plastics Business -- 2nd Update
04:57a BAYER : proposes increased dividend for 2014 of EUR 2.25 per share
04:10a BAYER : Financial News Conference -- Address by Johannes Dietsch -- Member of th..
04:10a BAYER : Financial News Conference -- Address by Dr. Marijn Dekkers -- Chairman o..
04:01aDJBayer Profit Falls Sharply as Costs Bite --Update
02:10aDJBayer Profit Falls Sharply as Costs Bite
02/25DJSanofi Wins Approval For New Insulin Drug
02/25DJSanofi Wins Approval For New Insulin Drug
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes